Shoulder Innovations (SI) Price to Sales (2025 - 2026)

Shoulder Innovations' (SI) quarterly Price to Sales came in at 24.59 in Q2 2026, up 36.56% quarter-over-quarter from 18.0 in Q1 2026.

Analysis

Shoulder Innovations (SI) Price to Sales (2025 - 2026) Analysis & Trends

Shoulder Innovations (SI) has reported Price to Sales for 2 consecutive years, with 24.59 the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Price to Sales changed N/A year-over-year to 24.59; the trailing twelve-month figure through Jun 2026 stood at 7.03 (changed N/A YoY), and the FY2025 full-year result was 2.62, changed N/A from the prior year.
Price to Sales climbed to 24.59 in Q2 2026 per SI's latest filing, from 18.0 in the prior quarter.
Across five years, Price to Sales topped out at 24.59 in Q2 2026 and bottomed at 8.6 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	184.79 Bn	179.19 Bn	7.27 Bn
2	Intuitive Surgical	124.16 Bn	118.95 Bn	1.96 Bn
3	Medtronic	118.51 Bn	109.69 Bn	6.34 Bn
4	Stryker	104.47 Bn	100.99 Bn	4.50 Bn
5	Boston Scientific	67.20 Bn	66.66 Bn	3.85 Bn
6	Edwards Lifesciences	49.85 Bn	45.59 Bn	1.35 Bn
7	Alcon	33.95 Bn	32.49 Bn	1.68 Bn
8	Dexcom	32.38 Bn	30.44 Bn	830.00 Mn
9	Steris	21.17 Bn	20.69 Bn	684.20 Mn
10	Shoulder Innovations	413.68 Mn	314.68 Mn	13.44 Mn

Historic Data

Download Data